Literature DB >> 21809131

The quantitative and qualitative responses of platelets in pediatric patients undergoing cardiopulmonary bypass surgery.

Vera Ignjatovic1, Jenny Than, Robyn Summerhayes, Fiona Newall, Steve Horton, Andrew Cochrane, Paul Monagle.   

Abstract

This prospective, single-center study aimed to evaluate the platelet response during cardiopulmonary bypass (CPB) surgery in a large cohort of children up to 6 years of age. Blood samples were drawn at four time points: after induction of anesthesia, after initiation of the CPB, before protamine, and immediately after chest closure. The study recruited 60 children requiring CPB for surgical repair of congenital heart defects. The platelet count decreased throughout CPB surgery, but during the same period, platelet activity increased. The more pronounced decrease in platelet count observed in children younger than 1 year compared with that of children 1 to 6 years of age was not associated with an age-specific change in platelet activity. The overall increase in platelet function observed in this study could provide a mechanism that compensates for the decrease in platelet count. This study provides a new foundation for future studies investigating requirements of platelet supplementation in the setting of pediatric CPB surgery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21809131     DOI: 10.1007/s00246-011-0079-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  15 in total

1.  Coagulation defects in neonates during cardiopulmonary bypass.

Authors:  F H Kern; N J Morana; J J Sears; P R Hickey
Journal:  Ann Thorac Surg       Date:  1992-09       Impact factor: 4.330

2.  Cardiopulmonary bypass induces significant platelet activation in children undergoing open-heart surgery.

Authors:  J Guay; P Ruest; L Lortie
Journal:  Eur J Anaesthesiol       Date:  2004-12       Impact factor: 4.330

Review 3.  The chemokines: their potential role in allergic inflammation.

Authors:  L M Teran; D E Davies
Journal:  Clin Exp Allergy       Date:  1996-09       Impact factor: 5.018

4.  Platelet activation and aggregation during normothermic cardiopulmonary bypass.

Authors:  Y Misawa; H Konishi; K Kawahito; K Fuse
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-01

5.  Is the use of albumin in colloid prime solution of cardiopulmonary bypass circuit justified?

Authors:  R H Boks; L A van Herwerden; J J Takkenberg; W van Oeveren; Y J Gu; M J Wijers; A J Bogers
Journal:  Ann Thorac Surg       Date:  2001-09       Impact factor: 4.330

6.  Predicting and treating coagulopathies after cardiopulmonary bypass in children.

Authors:  B E Miller; T Mochizuki; J H Levy; J M Bailey; S R Tosone; V K Tam; K R Kanter
Journal:  Anesth Analg       Date:  1997-12       Impact factor: 5.108

7.  Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery.

Authors:  G D Williams; S L Bratton; E C Riley; C Ramamoorthy
Journal:  J Cardiothorac Vasc Anesth       Date:  1999-08       Impact factor: 2.628

8.  Platelet hyporeactivity in young infants during cardiopulmonary bypass.

Authors:  F Ichinose; S Uezono; R Muto; H Uchida; F Hatori; K Terui; Y Niimi; T Goto; Y Nakata; S Morita
Journal:  Anesth Analg       Date:  1999-02       Impact factor: 5.108

9.  Unexpected persistence of platelet hyporeactivity beyond the neonatal period: a flow cytometric study in neonates, infants and older children.

Authors:  Nathalie Hézard; Gérard Potron; Nicole Schlegel; Catherine Amory; Bernard Leroux; Philippe Nguyen
Journal:  Thromb Haemost       Date:  2003-07       Impact factor: 5.249

10.  Platelet dysfunction after normothermic cardiopulmonary bypass in children: effect of high-dose aprotinin.

Authors:  Claire Flaujac; Philippe Pouard; Pierre Boutouyrie; Joseph Emmerich; Christilla Bachelot-Loza; Dominique Lasne
Journal:  Thromb Haemost       Date:  2007-08       Impact factor: 5.249

View more
  2 in total

1.  First report of elevated monocyte-platelet aggregates in healthy children.

Authors:  Christina Yip; Vera Ignjatovic; Chantal Attard; Paul Monagle; Matthew D Linden
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

Review 2.  Risk Factors, Prophylaxis, and Treatment of Venous Thromboembolism in Congenital Heart Disease Patients.

Authors:  Michael Silvey; Leonardo R Brandão
Journal:  Front Pediatr       Date:  2017-06-19       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.